Lingfei Wan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lingfei Wan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Bing Liu
State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Senior Department of Hematology, Fifth Medical Center, Medical Innovation Research Department, Chinese PLA General Hospital, Beijing, China
1 shared publication - Bing Sun
Department of Radiation Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
1 shared publication - Chao Liu
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
1 shared publication - Chen Ge
Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing 100124, China
1 shared publication Cong Wang
Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
1 shared publication- Hui Yang
Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing 100124, China
1 shared publication
Latest Publications
- Top Cited Papers
- 27 January 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (4) , eadd8977
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
Cervical squamous cell carcinoma (CESC) is a prototypical human cancer with well-characterized pathological stages of initiation and progression. However, high-resolution knowledge of the transcriptional programs underlying each stage of CESC is lacking, and important questions remain. We performed single-cell RNA sequencing of 76,911 individual cells from 13 samples of human cervical tissues at various stages of malignancy, illuminating the transcriptional tumorigenic trajectory of cervical epithelial cells and revealing key factors involved in CESC initiation and progression. In addition, we found significant correlations between the abundance of specific myeloid, lymphoid, and endothelial cell populations and the progression of CESC, which were also associated with patients’ prognosis. Last, we demonstrated the tumor-promoting function of matrix cancer–associated fibroblasts via the NRG1-ERBB3 pathway in CESC. This study provides a valuable resource and deeper insights into CESC initiation and progression, which is helpful in refining CESC diagnosis and for the design of optimal treatment strategies.
- 27 January 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (4) , eadd8977
Top Cited PapersSingle-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
Cervical squamous cell carcinoma (CESC) is a prototypical human cancer with well-characterized pathological stages of initiation and progression. However, high-resolution knowledge of the transcriptional programs underlying each stage of CESC is lacking, and important questions remain. We performed single-cell RNA sequencing of 76,911 individual cells from 13 samples of human cervical tissues at various stages of malignancy, illuminating the transcriptional tumorigenic trajectory of cervical epithelial cells and revealing key factors involved in CESC initiation and progression. In addition, we found significant correlations between the abundance of specific myeloid, lymphoid, and endothelial cell populations and the progression of CESC, which were also associated with patients’ prognosis. Last, we demonstrated the tumor-promoting function of matrix cancer–associated fibroblasts via the NRG1-ERBB3 pathway in CESC. This study provides a valuable resource and deeper insights into CESC initiation and progression, which is helpful in refining CESC diagnosis and for the design of optimal treatment strategies.